Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era

BACKGROUND: iPLEDGE is the mandatory regulatory program for isotretinoin in the United States, aimed to prevent isotretinoin-related teratogenicity. However, little is known about potential unintended impact of the program, including delay in isotretinoin initiation, course interruption, and prematu...

Descripción completa

Detalles Bibliográficos
Autores principales: Charrow, Alexandra, Xia, Fan Di, Lu, Jessica, Waul, Michael, Joyce, Cara, Mostaghimi, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435230/
https://www.ncbi.nlm.nih.gov/pubmed/30913210
http://dx.doi.org/10.1371/journal.pone.0210445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435230/
https://www.ncbi.nlm.nih.gov/pubmed/30913210
http://dx.doi.org/10.1371/journal.pone.0210445

Ejemplares similares